Pancreatic cancer survival prediction via inflammatory serum markers.
Mira A LankiHanna SeppänenHarri MustonenAino SalmiheimoUlf-Håkan StenmanMarko SalmiSirpa JalkanenCaj HaglundPublished in: Cancer immunology, immunotherapy : CII (2022)
Hs-CRP and the seven cytokines added to the reference model including CA19-9 are potential prognostic factors for improved survival prediction for PDAC patients.